(13)C/(31)P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease

The development of therapeutic clinical trials for glycogen storage disorders, including Pompe disease, has called for non-invasive and objective biomarkers. Glycogen accumulation can be measured in vivo with (13)C MRS. However, clinical implementation remains challenging due to low signal-to-noise....

Descripción completa

Detalles Bibliográficos
Autores principales: Baligand, Celine, Todd, Adrian G., Lee-McMullen, Brittany, Vohra, Ravneet S., Byrne, Barry J., Falk, Darin J., Walter, Glenn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626920/
https://www.ncbi.nlm.nih.gov/pubmed/29018835
http://dx.doi.org/10.1016/j.omtm.2017.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626920/
https://www.ncbi.nlm.nih.gov/pubmed/29018835
http://dx.doi.org/10.1016/j.omtm.2017.09.002

Ejemplares similares